Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-035093
Filing Date
2014-10-30
Accepted
2014-10-30 19:25:49
Documents
1
Period of Report
2014-10-30

Document Format Files

Seq Description Document Type Size
1 DIETZ FORM 4 rrd417667.html 4  
1 DIETZ FORM 4 rrd417667.xml 4 8751
  Complete submission text file 0001181431-14-035093.txt   10272
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICAL, INC. 1003 W. CUTTING BLVD, STE 110 PT. RICHMOND CA 94804
Business Address
Dietz Thomas John (Reporting) CIK: 0001574218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36066 | Film No.: 141184510